Now Available:
Watch video podcasts of the 2008 EULAR press conferences

CME Opportunity:

Arthritis: Disease Factors, Corticosteroids Nearly Double Heart Attack Risk in RA Patients
RA-specific factors and corticosteroid use significantly increase the risk of myocardial infarction in RA patients...

Consumer News: Bone Loss Stable on Restricted Calorie Diet
Overweight adults can shed pounds without experiencing significant bone loss by eating a low calorie diet that includes essential nutrients...

BioPharm Business: Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial of ALO-01 (Embeda) Capsules for Pain Relief in Patients With OA
If approved by the US FDA, ALO-01 would be the first opioid medicine to provide a pharmacologic abuse-deterrent feature while effectively treating patients with chronic pain...

BioPharm Business: Centocor's Ustekinumab Demonstrates Superior Efficacy to Enbrel (Etanercept) in Treatment of Moderate-to-Severe Plaque Psoriasis
A greater proportion of patients receiving ustekinumab achieved significant skin clearance versus patients receiving Enbrel...

Click here to remove your e-mail address from our mailing list. For questions and comments regarding this newsletter please contact .